64 reports of this reaction
1.4% of all BUFFERED ASPIRIN reports
#12 most reported adverse reaction
TUBULOINTERSTITIAL NEPHRITIS is the #12 most commonly reported adverse reaction for BUFFERED ASPIRIN, manufactured by Lil' Drug Store Products, Inc.. There are 64 FDA adverse event reports linking BUFFERED ASPIRIN to TUBULOINTERSTITIAL NEPHRITIS. This represents approximately 1.4% of all 4,540 adverse event reports for this drug.
Patients taking BUFFERED ASPIRIN who experience tubulointerstitial nephritis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TUBULOINTERSTITIAL NEPHRITIS is a less commonly reported adverse event for BUFFERED ASPIRIN, but still significant enough to appear in the safety profile.
In addition to tubulointerstitial nephritis, the following adverse reactions have been reported for BUFFERED ASPIRIN:
The following drugs have also been linked to tubulointerstitial nephritis in FDA adverse event reports:
TUBULOINTERSTITIAL NEPHRITIS has been reported as an adverse event in 64 FDA reports for BUFFERED ASPIRIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
TUBULOINTERSTITIAL NEPHRITIS accounts for approximately 1.4% of all adverse event reports for BUFFERED ASPIRIN, making it a notable side effect.
If you experience tubulointerstitial nephritis while taking BUFFERED ASPIRIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.